Petros Pharmaceuticals partners with Innolitics to accelerate SaaS platform development
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 20 2025
0mins
Source: SeekingAlpha
Partnership Announcement: Petros Pharmaceuticals has partnered with Innolitics to develop a SaaS platform that will integrate cloud-based components such as AI and cybersecurity for prescription treatments.
Market Reaction: Following the announcement, Petros Pharmaceuticals' stock rose by 6.43% in premarket trading, reaching $0.1406.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.





